Hla Drb1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Hla Drb1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
HLA-DRB1 (Major Histocompatibility Complex, Class II, DR Beta 1) encodes the beta chain of the HLA-DR heterodimer, a critical component of the major histocompatibility complex (MHC) class II molecule. This gene plays a central role in the adaptive immune response by presenting peptide antigens to CD4+ T helper cells. [@sawcer2011]
Gene Information
Normal Function
HLA-DRB1 is expressed primarily on antigen-presenting cells (APCs) including dendritic cells, macrophages, and B cells. The protein:
Forms heterodimers with HLA-DRA to create the HLA-DR molecule
Presents extracellularly derived peptide antigens to CD4+ T lymphocytes
Plays a critical role in initiating adaptive immune responses
Is highly polymorphic with over 600 known alleles
Influences immune response variability across individuals
Disease Associations
Alzheimer's Disease
HLA-DRB1 has been identified as an Alzheimer's disease risk gene through genome-wide association studies (GWAS). Specific alleles (DRB104:04, DRB115:01) have been associated with:
Increased AD risk in certain populations
Modulation of microglial immune responses
Amyloid plaque burden and neuroinflammation
The gene is involved in immune-mediated clearance of [amyloid-beta](/proteins/amyloid-beta)
Parkinson's Disease
Variants in HLA-DRB1 have been linked to:
Increased Parkinson's disease susceptibility
Modulation of [alpha-synuclein](/mechanisms/alpha-synuclein) clearance
Inflammatory responses in the substantia nigra
Multiple Sclerosis
HLA-DRB1*15:01 is the strongest known genetic risk factor for MS, demonstrating the gene's critical role in autoimmune demyelination.
Expression
HLA-DRB1 is expressed in:
Peripheral: B cells, dendritic cells, macrophages, monocytes
CNS: Activated [microglia](/entities/microglia) (particularly in neurodegenerative disease)
Therapeutic Implications
HLA-DRB1*15:01 is a target in MS drug development
Immune modulation therapies may affect neurodegenerative disease progression
Genetic testing for HLA-DRB1 variants informs MS treatment response
Key Publications
Lambert JC, et al. (2013) Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet 45:1452-1458. PMID: 24162737(https://pubmed.ncbi.nlm.nih.gov/24162737/)
International Parkinson's Disease Genomics Consortium (IPDGC) (2011) A two-stage meta-analysis identifies several new loci for Parkinson's disease. PLoS Genet 7:e1002147. PMID: 21738488(https://pubmed.ncbi.nlm.nih.gov/21738488/)
Sawcer S, et al. (2011) Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476:214-219. PMID: 21833088(https://pubmed.ncbi.nlm.nih.gov/21833088/)
The study of Hla Drb1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
See Also
Brain Atlas Resources
[Allen Human Brain Atlas - HLA-DRB1 Expression](https://human.brain-map.org/microarray/search/show?search_term=HLA-DRB1)
[Allen Cell Type Atlas - HLA-DRB1](https://celltypes.brain-map.org/)
[Gregersen JW, Kranc KR, Ke X, et al, (2006) (2006)](https://pubmed.ncbi.nlm.nih.gov/17053039/)
[Sawcer S, Hellenthal G, Pirinen M, et al, (2011) (2011)](https://pubmed.ncbi.nlm.nih.gov/21833088/)
[Unknown, International Multiple Sclerosis Genetics Consortium. (2013). Analysis of immune-related loci identifies 48 new susceptibility loci for MS. Nat Genet. 45(11):1153-1160 (2013)](https://pubmed.ncbi.nlm.nih.gov/23817571/)
[Patsopoulos NA, Barcellos LF, Hintzen RQ, et al, (2013) (2013)](https://pubmed.ncbi.nlm.nih.gov/23911757/)
[Lenz TL, Deutsch AJ, Han B, et al, (2015) (2015)](https://pubmed.ncbi.nlm.nih.gov/25910211/)